Both in Biotechnology
Pelthos Therapeutics vs Atara Biotherapeutics
Over the past year PTHS returned −30.3% and ATRA returned −41.7%; their daily moves had a correlation of 0.04.
PTHS −30.3% ATRA −41.7%Growth of $1, one year, split-adjusted
| Metric | PTHS | ATRA |
|---|---|---|
| Price | $20.92 | $8.05 |
| Market cap | $80.1M | $80.8M |
| Today | −1.55% | −3.82% |
| 1 month | −15.4% | −12.5% |
| 6 months | −0.4% | +86.3% |
| Year to date | −32.5% | −55.5% |
| 1 year | — | −41.4% |
| Revenue growth (YoY) | — | −96.4% |
| Gross margin | 76.9% | 69.7% |
| Net margin | −150.1% | −767.3% |
| P/E (TTM) | — | — |
| Price / sales | 1.8× | 13.0× |
| Net cash | -$45.7M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 72.5% | 65.7% |
| Short % of float | 6.8% | 15.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).